Wikipedia:WikiProject Chemicals/Chembox validation/VerifiedDataSandbox and Pefloxacin: Difference between pages
Appearance
(Difference between pages)
Content deleted Content added
Saving copy of the {{drugbox}} taken from revid 462362012 of page Pefloxacin for the Chem/Drugbox validation project (updated: 'DrugBank'). |
m →Licensed uses: HTTP to HTTPS for Wayback Machine, replaced: http://web.archive.org/ → https://web.archive.org/ (2) |
||
Line 1: | Line 1: | ||
{{short description |Antibiotic}} |
|||
{{ambox | text = This page contains a copy of the infobox ({{tl|drugbox}}) taken from revid [{{fullurl:Pefloxacin|oldid=462362012}} 462362012] of page [[Pefloxacin]] with values updated to verified values.}} |
|||
{{drugbox |
{{drugbox |
||
| |
| = changed |
||
| verifiedrevid = |
| verifiedrevid = |
||
| IUPAC_name = 1-ethyl-6-fluoro-7- |
| IUPAC_name = 1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid |
||
| image = Pefloxacin.svg |
| image = Pefloxacin.svg |
||
| width = 220 |
|||
| CASNo_Ref = {{cascite|correct|CAS}} |
|||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
||
| ChemSpiderID = 46291 |
| ChemSpiderID = 46291 |
||
| UNII_Ref = {{fdacite|correct|FDA}} |
| UNII_Ref = {{fdacite|correct|FDA}} |
||
| UNII = 2H52Z9F2Q5 |
| UNII = 2H52Z9F2Q5 |
||
| InChI = 1/C17H20FN3O3/c1-3-20-10-12(17(23)24)16(22)11-8-13(18)15(9-14(11)20)21-6-4-19(2)5-7-21/h8-10H,3-7H2,1-2H3,(H,23,24) |
|||
| InChIKey = FHFYDNQZQSQIAI-UHFFFAOYAD |
|||
| smiles = O=C(O)\C2=C\N(c1cc(c(F)cc1C2=O)N3CCN(C)CC3)CC |
| smiles = O=C(O)\C2=C\N(c1cc(c(F)cc1C2=O)N3CCN(C)CC3)CC |
||
| ChEMBL_Ref = {{ebicite|correct|EBI}} |
| ChEMBL_Ref = {{ebicite|correct|EBI}} |
||
Line 27: | Line 25: | ||
| ChEBI = 50199 |
| ChEBI = 50199 |
||
| PubChem = 51081 |
| PubChem = 51081 |
||
| DrugBank_Ref = {{drugbankcite| |
| DrugBank_Ref = {{drugbankcite||drugbank}} |
||
| DrugBank = DB00487 |
| DrugBank = DB00487 |
||
| KEGG_Ref = {{keggcite|correct|kegg}} |
| KEGG_Ref = {{keggcite|correct|kegg}} |
||
| KEGG = D02306 |
| KEGG = D02306 |
||
| C=17 | H=20 | F=1 | N=3 | O=3 |
| C=17 | H=20 | F=1 | N=3 | O=3 |
||
| molecular_weight = 333.358 g/mol |
|||
| bioavailability = 100% |
| bioavailability = 100% |
||
| protein_bound = 20–30% |
| protein_bound = 20–30% |
||
Line 47: | Line 44: | ||
| routes_of_administration = |
| routes_of_administration = |
||
}} |
}} |
||
'''Pefloxacin''' is a [[quinolone antibiotic]] used to treat bacterial infections. Pefloxacin has not been approved for use in the United States. |
|||
==History== |
|||
Pefloxacin was developed in 1979 and approved in France for human use in 1985.<ref>{{Cite court|litigants=Generics (UK) Limited v. Daiichi Pharmaceutical Co. Ltd & Daiichi Sankyo Co. Ltd|court=EWHC|pinpoint=2016-07-13|date=15 October 2008|url=http://www.bailii.org/ew/cases/EWHC/Patents/2008/2413.html}}</ref> |
|||
==Licensed uses== |
|||
*Uncomplicated gonococcal urethritis in males.<ref name="p_usage">{{Cite web |title=Reasons for prescribing Pefloxacin |url=http://www.pefloxacin.com/pefloxacin_usage.htm |archive-url=https://web.archive.org/web/20160305034519/http://www.pefloxacin.com/pefloxacin_usage.htm |archive-date=2016-03-05 |website=pefloxacin.com}}</ref> |
|||
*Bacterial infections in the gastrointestinal system.<ref name=p_usage/> |
|||
*Genitourinary tract infections.<ref name=p_usage/> |
|||
*Gonorrhoea, however, this use is no longer effective due to bacterial resistance.<ref>{{cite journal |title=Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections |journal=MMWR Morb. Mortal. Wkly. Rep. |volume=56 |issue=14 |pages=332–6 |date=April 2007 |pmid=17431378 |url=https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5614a3.htm |author= Centers for Disease Control and Prevention (CDC)}}</ref> |
|||
Pefloxacin has been increasingly used as a veterinary medicine to treat microbial infections.<ref>{{Cite web |title=Alternative uses for Pefloxacin |url=http://www.pefloxacin.com/pefloxacin_other.html |archive-url=https://web.archive.org/web/20160617061536/http://www.pefloxacin.com/pefloxacin_other.html |archive-date=2016-06-17 |website=pefloxacin.com}}</ref> |
|||
==Mode of action== |
|||
Pefloxacin is a [[broad-spectrum antibiotic]] that is active against both [[Gram-positive]] and [[Gram-negative]] bacteria. It functions by inhibiting [[DNA gyrase]], a type II [[topoisomerase]], and topoisomerase IV,<ref>{{cite journal |vauthors=Drlica K, Zhao X |title=DNA gyrase, topoisomerase IV, and the 4-quinolones |journal=Microbiol Mol Biol Rev |volume=61 |issue=3 |pages=377–92 |date=1 September 1997|doi=10.1128/mmbr.61.3.377-392.1997 |pmid=9293187 |pmc=232616 |url=}}</ref> which is an enzyme necessary to separate, replicated DNA, thereby inhibiting cell division. |
|||
==Adverse effects== |
|||
Tendinitis and rupture, usually of the Achilles tendon, are class-effects of the fluoroquinolones, most frequently reported with pefloxacin.<ref>{{cite journal |vauthors=Khaliq Y, Zhanel GG |title=Musculoskeletal injury associated with fluoroquinolone antibiotics |journal=Clin Plast Surg |volume=32 |issue=4 |pages=495–502, vi |date=October 2005 |pmid=16139623 |doi=10.1016/j.cps.2005.05.004 |url=http://journals.elsevierhealth.com/retrieve/pii/S0094-1298(05)00043-X}} |
|||
</ref> The estimated risk of tendon damage during pefloxacin therapy has been estimated by the French authorities in 2000 to be 1 case per 23,130 treatment days as compared to ciprofloxacin where it has been estimated to be 1 case per 779,600.<ref>{{cite journal |vauthors=Casparian JM, Luchi M, Moffat RE, Hinthorn D |title=Quinolones and tendon ruptures |journal=South. Med. J. |volume=93 |issue=5 |pages=488–91 |date=May 2000 |pmid=10832946 |doi=10.1097/00007611-200093050-00008}}</ref> |
|||
==References== |
|||
{{Reflist}} |
|||
{{QuinoloneAntiBiotics}} |
|||
==External links== |
|||
* [http://health.howstuffworks.com/cipro.htm How Stuff Works - Cipro] |
|||
* [http://www.oubari.com/modules.php?op=modload&name=My_eGallery&file=index&do=showpic&pid=112 Package insert information]{{Dead link|date=May 2020 |bot=InternetArchiveBot |fix-attempted=yes }} |
|||
[[Category:1,4-di-hydro-7-(1-piperazinyl)-4-oxo-3-quinolinecarboxylic acids]] |
|||
[[Category:Fluoroquinolone antibiotics]] |
|||
[[Category:Piperazines]] |